S18-301 Intranasal vasopressin to treat social impairments associated with autism Researchers at Stanford are developing methods of using arginine vasopressin (AVP) to improve social abilities of children with autism spectrum disorder (ASD). Autism is a neurodevelopmental disorder characterized by social impairments (e.g. Karen Parker Antonio Hardan Dean Carson